Short communication · 31 Jan 2025
EditorialPublished 1 Aug 2020
2020 Announcement of Chronic Obstructive Pulmonary Disease Conference
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Increasing prevalence of respiratory diseases owing to the growing aging population and increasing pathogens in the environment has been the key factor driving the Chronic Obstructive Pulmonary Disease (COPD) market globally. Pharmaceutical companies have been developing new biobased medications in combination with bio-technology which promises immense growth opportunities along with sustainable development for COPD market over the next decade.
Subjects
Pulmonology & RespiratoryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Chronic Obstructive Pulmonary Disease: Open Access.
Perspective · 31 Jan 2025
Cellular Senescence and Mitochondrial Dysfunction as Central Players
Opinion · 31 Jan 2025
Digital Twins in COPD: Simulation Models for Personalized Treatment
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalChronic Obstructive Pulmonary Disease: Open Access
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Xiaohong Zhou”
